Anchor Capital Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Anchor Capital Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,960	Closed	-$477K	–	241
2025 Q1	$477K	Sell	1,960 -95,247	-98%	-$28.7M	0.01%	205
2024 Q4	$31.9M	Sell	97,207 -553	-0.6%	-$188K	0.91%	47
2024 Q3	$32.7M	Buy	97,760 +12,190	+14%	+$3.87M	0.87%	49
2024 Q2	$23.4M	Sell	85,570 -14,461	-14%	-$4.21M	0.66%	56
2024 Q1	$34.6M	Buy	100,031 +23,333	+30%	+$7.67M	0.91%	48
2023 Q4	$24.8M	Sell	76,698 -20,844	-21%	-$6.53M	0.65%	55
2023 Q3	$35M	Buy	97,542 +24,889	+34%	+$9.6M	0.98%	42
2023 Q2	$27.5M	Buy	+72,653	New	+$29.6M	0.71%	50

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Anchor Capital Advisors's BIO Position: Q2 2025 in Review

Anchor Capital Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 1,960 shares — an estimated $477K sold.

Anchor Capital Advisors first reported a position in BIO in Q2 2023 and held it in 8 quarters. The position peaked at $35M in Q3 2023. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Anchor Capital Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
Anchor Capital Advisors sold 1,960 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $477K.
Anchor Capital Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and held it in 8 quarters.
Anchor Capital Advisors's Bio-Rad Laboratories Class A position peaked at $35M in Q3 2023.
383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Anchor Capital Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.